Mitchall Clark

General Counsel at WHITEHAWK THERAPEUTICS, INC.

65 year

Health Technology

Consumer Services

Technology Services

Profile

Mitchall G.
Clark is a Senior VP-Regulatory Affairs & Quality Assurance at Aadi Bioscience, Inc. He previously held positions as Senior Director-Regulatory Affairs at Faulding, Inc. and American Bioscience, Inc., Vice President-Regulatory Affairs at APP Pharmaceuticals, Inc., Senior Vice President-Global Regulatory Affairs at Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs at Celgene Corp., NantWorks LLC, and Abraxis BioScience, Inc., Senior Vice President-Regulatory Affairs & Quality at NantPharma LLC, and Chief Regulatory & Quality Assurance Officer at Atara Biotherapeutics, Inc. He also worked as a Principal at Lindum Pharmaceutical Services Corp.
Mr. Clark received an undergraduate degree from The University of Nottingham.

Mitchall Clark active positions

Companies	Position	Start
WHITEHAWK THERAPEUTICS, INC.	General Counsel	01/08/2018

All active positions of Mitchall Clark

Former positions of Mitchall Clark

Companies	Position	End
Lindum Pharmaceutical Services Corp.	Corporate Officer/Principal	01/03/2014
NantPharma LLC NantPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures injectable pharmaceutical products	General Counsel	01/06/2013
CELGENE	General Counsel	01/06/2011
Abraxis BioScience, Inc. Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products	General Counsel	01/11/2007
Abraxis BioScience, Inc. /Old/ Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products	General Counsel	01/04/2006

See the detail of Mitchall Clark's experience

Training of Mitchall Clark

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mitchall Clark's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Celgene Corp. Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs	Health Technology
Faulding, Inc. Faulding, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells generic drugs	Health Technology
American Bioscience, Inc. American Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations	Health Technology
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations	Health Technology
Abraxis BioScience, Inc. Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products	Health Technology
APP Pharmaceuticals, Inc. APP Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops, manufactures and markets injectable pharmaceutical products	Health Technology
The University of Nottingham The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Abraxis BioScience, Inc. /Old/ Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures specialty pharmaceutical products	Health Technology
NantWorks LLC NantWorks LLC Packaged SoftwareTechnology Services Develops and delivers technologies that accelerate to scientific discovery, enhance ground-breaking research and improve healthcare treatment	Technology Services
NantPharma LLC NantPharma LLC Pharmaceuticals: MajorHealth Technology Manufactures injectable pharmaceutical products	Health Technology
Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases	Health Technology
Lindum Pharmaceutical Services Corp.
Aadi Bioscience, Inc. Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases	Health Technology